New sensor aims to take the guesswork out of IV fluids during surgery
NCT ID NCT03706430
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new sensor measure called RPVi to see if it can predict how patients will respond to fluids during surgery. Researchers compared RPVi to standard methods in 63 adults having elective surgery. The study was terminated early, so the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Pulse CO-Oximeter sensor (device)
- What this could lead to
- If successful, this could improve how doctors manage fluids during surgery, potentially reducing complications.
- What could go wrong
- The study was terminated early with only 63 participants, so results are limited and may not be reliable. The device is still investigational.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
63 people
The number who actually took part.
- Started
-
Sep 2018
- Finished
-
Oct 2021
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years of age or older at the time of consent * Scheduled for elective surgery requiring general anesthesia and mechanical ventilation * Arterial line and other standard of care line placement indicated as part of the scheduled surgical procedure Exclusion Criteria: * Patients diagnosed with or history of heart failure, angina, pulmonary heart disease, rheumatic heart disease, cardiomyopathy, congenital heart disease, or valvular heart disease. * Patients scheduled for or has had a liver transplant * Patients with surgeries at or around site of sensor placement or skin abnormalities affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails that would prevent monitoring of pulse-oximeter physiological parameters during the study. * Patients with cardiac arrhythmias * Patients with intracardiac shunts
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anesthesia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fixing broken ribs with surgery may cut pain better than drugs alone
- Ultrasound peers into Children's stomachs after Pre-Surgery drink
- Can Weight-Loss surgery patients skip the opioids?
- What stops surgeons from trying new techniques? 260 cancer surgeons asked
- Can IV nutrition at an outpatient clinic help malnourished surgery patients?
- Can a gentler anesthesia cocktail protect a child's developing brain?